Cyber Monday SALE! GET 20% Off! Use Code CM20 *
This item cannot be shipped to Minnesota, Canada and P.O. Boxes. Use must be approved by your veterinarian.
All vaccines are shipped via the Vaccine Shipping method. A $34.95 flat rate fee is charged for all orders containing vaccines. Vaccines are shipped in insulated packaging with ice in order to deliver chilled and someone should be present to sign for and receive the vaccine. For more shipping info click here.
During these hot summer months, we highly encourage shipping this item via Express (1-2 day); we cannot be held responsible for items that are shipped Priority (2-4 day) as the ice will not last that long.
NASALGEN® IP is for the vaccination of healthy cattle as an aid in the prevention of disease caused by infectious bovine rhinotracheitis and parainfluenza3 virus. Nasalgen IP vaccine is safe for use in pregnant cows or in calves nursing pregnant cows. Calves vaccinated under 5 months of age should be revaccinated at 5 months of age or weaning.
Aseptically rehydrate Nasalgen® IP vaccine with the enclosed diluent. Administer 2 mL into one nostril or 1 mL into each nostril for a 2 mL dose, using a separate disposable cannula for each animal.
Nasalgen® IP vaccine is safe for use in pregnant cows or in calves nursing pregnant cows. Calves vaccinated under 5 months of age should be revaccinated at 5 months of age or weaning.
FOR INTRANASAL USE ONLY
FOR ANIMAL USE ONLY
Store at 2°-7°C (35°-45°F). Use entire contents when first opened. Do not use chemical disinfectants to sterilize syringes, needles or cannulas. Burn container and all unused contents. Do not vaccinate within 21 days before slaughter. Anaphylactoid reactions may occur following use, treat with epinephrine. Contains gentamicin as a preservative.
This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy. This level of performance may be affected by conditions of use such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions